Skip to content

comparison of drugs for post operative pain relief in caesarean section

Comparison of the Analgesic Efficacy of Wound Infiltration with Tramadol versus Bupivacaine for Postoperative Pain Relief in Caesarean Section under subarachnoid block: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050565
Enrollment
80
Registered
2023-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z488- Encounter for other specified postprocedural aftercare Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Administration of either tramadol or bupivacaine: Prophylactic wound infiltration with either tramadol or bupivacaine. Inj.Tramadol hydrochloride 2 mg/kg in 20 mL of 0.9% normal saline,

Sponsors

Maharaja Agrasen Medical College, Agroha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. American Society of Anaesthesiologistsâ?? physical status II. 2. Patients undergoing caesarean section under subarachnoid block.

Exclusion criteria

Exclusion criteria: Patients 1. who refuse to give consent 2. with severe cardiopulmonary, renal or liver disease, pre-eclampsia, eclampsia, seizure disorder. 3. with contraindication to spinal anaesthesia like local site infections, coagulopathies or any spinal deformities. 4. who have infection at surgical site. 5. with history of allergy or hypersensitivity to local anaesthetics 6. with psychiatric illness that would interfere with assessment of pain will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Comparison between the analgesic efficacy of wound infiltration with tramadol and bupivacaine for postoperative pain using NRS and time of rescue analgesia.Timepoint: Assessment of post operative pain and time of rescue analgesia for upto 24 hours.

Secondary

MeasureTime frame
Incidence of adverse events.Timepoint: 24 hours post operative.

Countries

India

Contacts

Public ContactRUCHIKA KATHURIA

Maharaja Agrasen Medical College, Agroha, Hisar

drvibhamehta1@gmail.com08053440544

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026